
From discovery to clinical development, providing integrated support across the therapeutic lifecycle.
Supporting diverse modalities including CGT, antibodies, ADCs, bispecifics, vaccines, and emerging therapies.
Integrating advanced technologies, including high-throughput TR-FRET, rapid testing platforms, and AI-enabled solutions, to accelerate next-generation drug development.

Turning AI-designed sequences into validated candidates through integrated, scalable screening and experimental validation.

Tackling bioprocessing bottlenecks to improve efficiency, enhance performance, and overcome manufacturing challenges.

Powered by next-generation technology, preserving natural bioactivity for highly specific and sensitive CAR-T cell detection by FACS.

Resilient Supply provides flexible, high-quality GMP manufacturing for critical CGT reagents.

End‑to‑end support for in vivo CAR‑T – from quality characterization to clinical readiness, backed by reliable reagents and analytical platforms.

Versatile tools and services for the whole workflow to accelerate innovative antibody drug development.

Covering target proteins, cell lines, assay kits, antibody tools and analytical services.
 Development.png)
We offer end-to-end ADC products and services — from discovery and CMC QC to preclinical & clinical development—accelerating ADC innovation and design.

Accelerate Your Path to Clinical-Grade Cell and Gene Therapies

TR-FRET kits for diverse applications,Toolbox and customized development service to help rapidly establish reliable detection systems.

Reliable testing for endotoxins, mycoplasma, sterility, and other critical quality attributes.

Residue detection solutions for biopharmaceutical quality control and regulatory compliance.

Infectious diseases are caused by pathogens. We provide core reagents for accelerating the development and clinical trials of vaccines and therapeutic drugs.